LV-232

N/A

Report date: 2025/05/27 11:13:33
NME

Base Information

Drug NameLV-232
Drug Alias NameLV-232
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Vigonvita Life Sciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNantong Hefeng Lianwang Pharmaceutical Technology Co LtdSuzhou Vigonvita Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A